Amnesia Haze x SCBDx by SuperCBDx: A Comprehensive Strain Guide

Overview

Amnesia Haze x SCBDx is a mostly sativa hybrid that blends the electric, citrus-forward clarity of Amnesia Haze with the calming, CBD-rich backbone of SuperCBDx’s flagship breeding line. Bred by SuperCBDx, the cross was developed to deliver a Haze experience that is more approachable, with a higher likelihood of balanced or CBD-dominant chemotypes. This positions the cultivar as a bridge between high-energy daytime sativas and functional wellness-oriented cannabis.

In practice, growers and consumers can expect vigorous sativa structure, a terpene profile dominated by terpinolene, myrcene, and ocimene, and cannabinoid ratios that skew toward Type II (balanced THC:CBD) and Type III (CBD-dominant) outcomes. Typical indoor flowering time runs 9.5–11 weeks, with indoor yields commonly reported in the 450–600 g/m² range under competent lighting and canopy management. Its aroma leans into lemon zest, sweet tropical haze, and pine with a peppery-spiced finish, while the effect profile often combines uplifted focus with a buffered, low-anxiety body calm.

For patients and performance-minded consumers, the value proposition is specificity: a Haze that retains the mental lift but tempers edge, often via 6–14% CBD in balanced phenotypes. For cultivators, the strain rewards training and environmental control with long, lacquered colas that are lighter than indica buds yet surprisingly resinous. The result is a versatile cultivar that can be steered toward either spirited headspace or daily-function wellness depending on phenotype selection and harvest timing.

History and Breeding

The story of Amnesia Haze x SCBDx begins with two very different goals in cannabis breeding coming to a productive crossroads. Amnesia Haze, popularized in the early 2000s and associated with Dutch coffee shop culture and multiple High Times Cannabis Cup wins, became a synonym for euphoric, citrus-kissed sativas. Its genetic tapestry is thought to weave Southeast Asian, Jamaican, and Afghani influences into a classic Haze frame known for extended flowering and soaring head effects.

SuperCBDx entered the scene with a laser focus on CBD-rich lines, building a proprietary high-CBD male (often referred to simply as SCBDx) that they used to “CBD-ify” celebrated THC cultivars. The strategy was straightforward: introduce a consistent CBD locus and stabilize for functional cannabinoid ratios while retaining as much of the original cultivar’s organoleptic signature as possible. By crossing Amnesia Haze with SCBDx, the breeder pursued a sativa that could be used more flexibly by a broader range of consumers, including those sensitive to THC.

This project reflects a broader market trend that accelerated after 2013 as CBD entered mainstream awareness. Between 2015 and 2020, consumer interest in CBD-dominant flower and 1:1 flower increased substantially, with dispensary datasets showing balanced ratios representing a growing minority share in several markets. Amnesia Haze x SCBDx sits cleanly in that movement, offering a heritage flavor and effect memory with a modern, wellness-compatible cannabinoid architecture.

Genetic Lineage and Phenotypic Expectations

Genetically, Amnesia Haze x SCBDx is a mostly sativa hybrid that expresses long internodes, narrow-fingered leaves, and a pronounced stretch at the onset of 12/12. Phenotypically, this translates into plants that can double or even 2.2x their height during the first three weeks of flower, often necessitating trellising or a Screen of Green. Growers should anticipate a tall frame reaching 100–160 cm indoors in moderate veg periods, and substantially taller outdoors in long-season climates.

Chemotype expression in this cross typically segregates into the three classical categories. Type II (balanced) phenotypes are commonly encountered and often fall around 6–12% THC with 6–14% CBD, frequently approximating 1:1 by mass. Type III (CBD-dominant) phenotypes appear as well, generally showing 0.5–3% THC with 10–18% CBD under optimized cultivation, while Type I (THC-dominant) phenotypes are less common but possible, sometimes reaching 14–20% THC with sub-1% CBD.

The expected flowering window is 9.5–11 weeks indoors, shorter than many pure Hazes yet still reflective of its sativa core. Outdoor growers in temperate zones should target late October to early November harvests in the Northern Hemisphere, depending on latitude and seasonal weather. Total terpene content typically falls in the 1.5–2.5% range by dry weight, with variability tied to light intensity, post-harvest handling, and phenotype.

From a selection standpoint, the breeder’s SCBDx influence tends to stabilize CBD presence, but terpene dominance can swing. Many keepers express terpinolene-leading bouquets, while others tilt toward myrcene-forward citrus-herbal tones. For those seeking the classic Hazey aroma with added CBD, prioritize phenotypes that exhibit strong lemon-pine-lime aromatics early in flower and maintain citrus terps through week 8–10.

Appearance and Bud Structure

Amnesia Haze x SCBDx presents as a sativa-leaning cultivar with elongated colas and a medium calyx-to-leaf ratio that can reach 2.5:1 to 3.5:1 in well-lit zones. Buds are often speared and foxtail lightly in late flower when pushed with high PPFD or elevated temperatures, which can be aesthetic rather than problematic if managed. The coloration skews lime to forest green with bronze to tangerine stigmas that coil densely after week 7.

Trichome coverage is abundant for a CBD-inclusive cultivar, forming a sugary lacquer that is quite apparent under magnification by mid-flower. Resin heads are mostly medium-sized capitate-stalked trichomes, with a proportion of smaller heads appearing in lower light sites. In well-run rooms with 900–1100 µmol/m²/s of PPFD, the upper canopy can appear almost white-frosted by week 8–9.

Stems are flexible but benefit from structural support due to the sativa stretch and the weight of long colas late in bloom. Internodes are elongated, often 3–6 cm apart in veg under moderate intensity, tightening somewhat under high DLI. Leaf morphology is narrow-lanceolate, with 7–11 serrated fingers being common on mature fans.

Aroma and Terpene Expression

The dominant aromatic impression is bright and zesty, led by lemon peel and sweet tropical haze, often punctuated by green pine and a peppery, incense-like finish. When the jar is first cracked, expect a flash of terpinolene’s fruity-bright top note, followed by limonene’s candy-citrus and an undercurrent of wood resin and spice from caryophyllene. As the buds break, volatile floral and herbal layers appear, hinting at ocimene and linalool.

In flower, live plants carry a clean citrus bouquet that intensifies around week 6–8 as monoterpene production peaks. Many phenotypes evolve from sweet-lemon and lime zest early to a more complex lemon-pine-sandalwood late bloom. Dry and cure can shift the profile toward deeper incense and cedar if cured long, particularly in glass with controlled humidity.

Quantitatively, total terpene content often lands between 1.5% and 2.5% by dry weight under average conditions, with top performers touching 3.0% when environmental stress is minimized. Individual terpene contributions commonly observed: terpinolene 0.30–0.80%, myrcene 0.25–0.70%, ocimene 0.10–0.40%, limonene 0.15–0.45%, beta-caryophyllene 0.10–0.35%, and alpha-pinene 0.05–0.20%. These figures vary with phenotype, light intensity, and post-harvest handling, but the citrus-haze-pine triad is remarkably consistent.

Flavor Profile

On the palate, Amnesia Haze x SCBDx delivers a clean lemon-lime entry that quickly expands into herbal haze and sweet pine. Vaporization at 180–195°C reveals layered candy citrus with a cool, menthol-adjacent herbal lift that many attribute to terpinolene and alpha-pinene synergy. A peppery, slightly woody exhale lingers, suggestive of caryophyllene’s spicy bite and a ribbon of cedar.

Combustion tends to broaden the spice and resin components, bringing out a gentle sandalwood and a whisper of clove, especially with longer cures. In contrast, low-temp dabs of solventless rosin made from this cultivar can emphasize the top-note citrus and floral edges, registering almost sherbet-like at 175–185°C. Across formats, the flavor is precise and linear, rarely muddied, and generally retains its citrus backbone through the entire session.

Water-cured or aggressively dried material can lose the bright limonene sparkle, so careful dry and cure are essential to preserve the lemon-haze identity. Many connoisseurs report best flavor stability when the final water activity is held near 0.60–0.62 a_w and humidity at 58–62% RH. Under those conditions, the citrus and pine maintain intensity for 8–12 weeks in sealed glass.

Cannabinoid Profile and Lab Expectations

Because of the SCBDx contribution, cannabinoid outcomes cluster more predictably around balanced or CBD-forward chemotypes than standard Amnesia Haze. In practical terms, seed lots commonly produce a majority of Type II and Type III plants, with approximate distributions observed by many growers: Type II 50–65%, Type III 20–30%, and Type I 10–20%. Actual rates depend on selection and breeder lot, but these bands are a useful planning metric.

Typical lab ranges under optimized indoor cultivation are as follows. Type II phenotypes: 6–12% THC, 6–14% CBD, with total cannabinoids often 15–22%. Type III phenotypes: 0.5–3% THC, 10–18% CBD, total cannabinoids 12–20%. Less common Type I phenotypes: 14–20% THC, 0.1–1% CBD, total cannabinoids 18–26%.

Minor cannabinoid expression can be notable, especially for cannabigerol (CBG), which is often detected at 0.3–1.2%. Cannabichromene (CBC) can appear around 0.1–0.5%, and trace tetrahydrocannabivarin (THCV) at 0.05–0.3% in some hazy phenotypes. Extractors typically report flower rosin yields of 18–24% with well-grown material, reflecting robust resin production despite CBD presence.

For decarboxylation planning, expect ~12–13% mass loss associated with CO2 off-gassing when converting THCA/CBDA to THC/CBD. Edible formulators often target 110–115°C for 40–50 minutes for high-CBD material to balance conversion and terpene preservation. Always verify with small pilot batches, as matrix and moisture content can influence effective decarb kinetics.

Terpene Profile and Chemistry

The terpene architecture of Amnesia Haze x SCBDx is a textbook example of a terpinolene-driven, citrus-haze chemotype modified by CBD-friendly supporting terpenes. Terpinolene frequently leads at 0.30–0.80%, lending fruity-lime top notes and a crisp, lucid vibe many associate with daytime usability. Myrcene commonly follows at 0.25–0.70%, offering herbal depth and gentle musk that rounds sharp citrus.

Ocimene (0.10–0.40%) contributes a green, sweet, slightly tropical lift that works synergistically with limonene (0.15–0.45%) to intensify lemon zest on both aroma and palate. Beta-caryophyllene (0.10–0.35%) builds a peppery-spice finish and is unique for its CB2 receptor affinity, which some researchers hypothesize may influence perceived anti-inflammatory effects. Alpha-pinene (0.05–0.20%) and linalool (0.03–0.12%) show up as secondary characters, adding pine brightness and a faint floral thread.

Total terpene content of 1.5–2.5% is common with room to exceed 3.0% in high-performance grows that optimize DLI and VPD. Environmental factors like light spectrum (e.g., 5–12% 660 nm red and 3–6% 730 nm far-red supplementation in flower) and post-harvest curing conditions can materially shift both absolute and relative terpenes. For instance, overly warm drying (above 22–23°C) can disproportionately volatilize monoterpenes like terpinolene and limonene, flattening the top notes.

From a functional chemistry standpoint, terpinolene- and limonene-forward profiles are often reported to feel alerting and mood-elevating. The presence of CBD in many phenotypes may temper the anxious edge that some consumers experience with terpinolene-dominant sativas. This chemical framing helps explain why many find the cultivar both clear and composed rather than jittery.

Experiential Effects and Use Cases

Most users describe a bright, fast-onset cerebral lift within 2–5 minutes of inhalation, often accompanied by improved focus and a light, buoyant mood. In balanced or CBD-dominant phenotypes, this is tempered by a soft body ease that keeps the experience functional and reduces the likelihood of racing thoughts. The headspace is distinctly sativa, with many reporting enhanced ideation, conversation, and task engagement.

Duration commonly runs 2–3 hours for inhaled routes, with a clean taper that avoids heavy sedation. Oral formats extend the window to 6–8 hours with a 45–90-minute onset, and balanced chemotypes tend to produce a steadier line than THC-dominant sativas. Side effects can include dry mouth, mild dry eyes, and, in THC-leaning phenotypes, occasional racy moments, particularly with high doses or caffeine pairing.

Use cases cluster around daytime and project work, creative brainstorming, social settings, and light outdoor activity. Many consumers choose it as a pre-workout focus aid or for afternoon slumps, citing the combination of clarity and calm. Those sensitive to THC often prefer Type II or Type III phenotypes to retain the Haze vibe without overstimulation.

Tolerance and individual variability remain significant. Consumers who are very THC-sensitive may still find Type I phenotypes too edgy, whereas experienced users might prefer the brighter push of a slightly THC-tilted keeper. As always, start low, especially with novel phenotypes whose ratios and terpene intensities are unknown.

Potential Medical Applications

Amnesia Haze x SCBDx’s frequent presence of CBD alongside moderate THC makes it a candidate for symptom sets where daytime function is a priority. Survey data from medical markets consistently show pain, anxiety, and depression among leading reasons for cannabis use, and balanced chemotypes are commonly selected to reduce intoxication while retaining efficacy. The terpinolene-limonene-caryophyllene triad may subjectively support mood and perceived stress relief for some users.

For pain, clinical reviews have reported modest but statistically significant improvements in chronic pain intensity for a subset of patients using cannabinoid therapies. Balanced THC:CBD products can be preferable for neuropathic pain or musculoskeletal discomfort where THC alone is not well tolerated. CBD levels in the 6–14% range commonly seen in Type II phenotypes may also appeal to patients seeking anti-inflammatory support alongside functional analgesia.

Anxiety responses vary widely, but users who tend to experience THC-induced jitters often report improved tolerability with balanced ratios. CBD-dominant expressions (10–18% CBD, sub-3% THC) can provide a calm baseline with minimal intoxication, making them practical for social anxiety or daytime stressors. The presence of caryophyllene, a CB2 ligand, is frequently cited in preclinical literature for potential anti-inflammatory and anxiolytic properties, though clinical translation is still developing.

For nausea and appetite modulation, the sativa headspace combined with manageable intoxication may be helpful to some, especially in the context of chemotherapy-related symptoms where CBD-rich options are considered. As with any medical use, individual responses vary, and professional guidance is advisable. Patients should consult clinicians and consider lab-verified products to match cannabinoid ratios and terpene profiles to their goals.

Comprehensive Cultivation Guide

Amnesia Haze x SCBDx rewards growers who respect its sativa stretch and manage canopy architecture early. Germination is straightforward, with viable seed lots typically showing 90–95% germination under standard conditions. Start seeds in a light, aerated medium at 24–26°C with gentle moisture; seedlings prefer 250–400 µmol/m²/s PPFD and 65–75% RH for the first 10–14 days.

<